Regulation of PBP2x Surface Localization by aliD and clpL Alters β-Lactam Resistance in Pneumococcus

Area of Science:

• Microbiology
• Molecular Biology
• Antibiotic Resistance

Background:

• Streptococcus pneumoniae causes respiratory infections and exhibits resistance to beta-lactam antibiotics.
• Penicillin-binding protein (PBP) mutations drive beta-lactam resistance, but PBP regulation is not fully understood.

Purpose of the Study:

• Investigate the role of the oligopeptide-binding protein AliD in regulating beta-lactam antibiotic susceptibility in S. pneumoniae.
• Elucidate the molecular mechanisms by which AliD influences antibiotic resistance.

Main Methods:

• Comparative analysis of beta-lactam minimum inhibitory concentrations (MICs) in wild-type and aliD mutant strains.
• Gene expression analysis of clpL in the presence and absence of antibiotics.
• Assessment of PBP2x surface exposure and cell wall cross-linking.

Main Results:

• AliD expression elevated amoxicillin and cefdinir MICs, but not vancomycin MICs.
• AliD increased clpL expression, which directly correlated with decreased beta-lactam susceptibility.
• Elevated clpL expression enhanced PBP2x surface exposure and increased cell wall cross-linking.

Conclusions:

• AliD regulates beta-lactam susceptibility through a pathway involving increased clpL expression, PBP2x surface exposure, and peptidoglycan cross-linking.
• This study identifies a novel regulatory mechanism contributing to pneumococcal antibiotic resistance.
• Oligopeptide sensing may play a role in modulating antibiotic susceptibility in specific host environments.